Efficacy of SGLT2 inhibitor for nonalcoholic fatty liver disease: a randomized controlled trial
Not Applicable
- Conditions
- onalcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000026057
- Lead Sponsor
- Tohoku university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
other chronic hepatitis patients alcoholic hepatitis patients with hepatocellular carcinoma type 1 diabetes BMI under 20
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method liver function and steatosis after 24 months
- Secondary Outcome Measures
Name Time Method